Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by subaru1ion Jan 23, 2024 12:50pm
115 Views
Post# 35841129

RE:RE:RE:Over a month now and no news !!!

RE:RE:RE:Over a month now and no news !!!Redwine12345, understand what you are saying but there has to be exceptions to that general rule.  LABS did not announce anything for around 6 months that they were in negotiations with VIVO to acquire them.   Material news, not sure, could be defined as something that has an immediate impact to the balance sheet/income statement.   There could be very big news pending but until what ever that news is commercialized, they may not have to announce it immediately.   

Here's an example of what I'm talking about.   The FDA has approved the New Drug Application that LABS and their global pharma partner have been working on together.  Does it have a TRUE material impact immediately relative to the FDA approval?  From my understanding the FDA approval does not immediately impact the balance sheet or the earnings statements because the FDA approval has to be commercialized and in my own simple head I would say that upon direction from LABS that it will be commericalized on a fixed start date, then news would have to be released relative to that event.   

It's an example reflecting law/regulation versus the emotional impact of the news would have on investors, ie...the stock price rising because of the news but the news has not been commercilaized yet.  

That is kind of where my head is at for the time being.  
<< Previous
Bullboard Posts
Next >>